6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

10:00 AM - 10:30 AM

Key challenges and controversies in precision oncology

10:30 AM - 10:45 AM

Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD

10:45 AM - 11:00 AM

Current targeted therapies for germline alterations – Melinda L. Telli, MD

11:00 AM - 11:15 AM

Near-Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine

11:15 AM - 11:45 AM

Panel Discussion

11:45 AM - 12:00 PM

NHS-Galleri Trial

12:00 PM - 12:15 PM

Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD

12:15 PM - 12:30 PM

Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression

12:30 PM - 01:00 PM

Panel Discussion

01:45 PM - 02:00 PM

Target Discovery – Dennis Slamon, MD, PhD

02:00 PM - 02:15 PM

Novel ADC Linker/Payload Considerations

02:15 PM - 02:30 PM

Therapeutic strategies targeting brain metastases

02:30 PM - 03:00 PM

Panel Discussion

04:20 PM - 04:35 PM

Adaptive Feedback and Bypass Pathways

04:35 PM - 04:50 PM

Mechanisms of ADC Resistance – Naoto Ueno, MD, PhD, FACP

04:50 PM - 05:05 PM

Tumor Microenvironment Role – Judith A. Varner, PhD

05:05 PM - 05:35 PM

Panel Discussion